Recombinant human antithrombin (ATryn)

Mark Abramowicz, Gianna Zuccotti, Jean Marie Pflomm, Susan M. Daron, Blaine M. Houst, Corinne E. Zanone, Jules Hirsch, Gerald L. Mandell, Dan M. Roden, Carl W. Bazil, Vanessa K. Dalton, Eric J. Epstein, David N. Juurlink, Richard B. Kim, Hans Meinertz, Sandip K. Mukherjee, F. Estelle R. Simons, Jordan W. Smoller, Neal H. Steigbigel, Donna GoodsteinAmy Faucard, Cynthia Macapagal Covey, Vincent Teo, Susie Wong, Liz Donohue, Cheryl Brown, Gene Carbona, Cristine Romatowski, Joanne F. Valentino, Yosef Wissner-Levy

Research output: Contribution to journalShort survey

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)83-84
Number of pages2
JournalMedical Letter on Drugs and Therapeutics
Volume51
Issue number1323
StatePublished - Oct 19 2009

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

Abramowicz, M., Zuccotti, G., Pflomm, J. M., Daron, S. M., Houst, B. M., Zanone, C. E., Hirsch, J., Mandell, G. L., Roden, D. M., Bazil, C. W., Dalton, V. K., Epstein, E. J., Juurlink, D. N., Kim, R. B., Meinertz, H., Mukherjee, S. K., Simons, F. E. R., Smoller, J. W., Steigbigel, N. H., ... Wissner-Levy, Y. (2009). Recombinant human antithrombin (ATryn). Medical Letter on Drugs and Therapeutics, 51(1323), 83-84.